Gel approved for KS.
出版信息
AIDS Patient Care STDS. 1999 May;13(5):309. doi: 10.1089/apc.1999.13.309.
PMID:10356816
Abstract
摘要
相似文献
1
Gel approved for KS.
AIDS Patient Care STDS. 1999 May;13(5):309. doi: 10.1089/apc.1999.13.309.
2
KS drug goes to FDA. Food and Drug Administration.
GMHC Treat Issues. 1998 May;12(5):7.
3
Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
Arch Dermatol. 2000 Dec;136(12):1461-9. doi: 10.1001/archderm.136.12.1461.
4
Oral treatment for KS.
Posit Aware. 1998 Sep-Oct;9(5):18.
5
Early approval for two lipid-based drugs.
BETA. 1995 Dec:4.
6
Kaposi's sarcoma: new topical treatment approved.
AIDS Treat News. 1999 Feb 19(No 313):1.
7
Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.
J Acquir Immune Defic Syndr. 1999 Nov 1;22(3):235-46. doi: 10.1097/00126334-199911010-00004.
8
Topical 0.1% alitretinoin gel for classic Kaposi sarcoma.
Arch Dermatol. 2002 Apr;138(4):542-3. doi: 10.1001/archderm.138.4.542.
9
Alitretinoin (Panretin) gel 0.1%.
J Assoc Nurses AIDS Care. 2001 Sep-Oct;12(5):86-91. doi: 10.1016/S1055-3290(06)60266-5.
10
[Kaposi's sarcoma treated with topical alitretinoin].
Actas Dermosifiliogr. 2007 Jan-Feb;98(1):50-3.
Zotero 插件